U.S. CDMRP – Tuberous Sclerosis Complex Research Program (TSCRP) | Research Funding
Event details
| Date | 12.06.2024 |
| Category | Call for proposal |
Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2024 Tuberous Sclerosis Complex Research Program (TSCRP) Awards. Several award programs are available:
- The Clinical Translational Research Award supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis, or treatment of TSC.
Applications must address at least one of the FY2024 focus areas listed in this document.
- The Exploration - Hypothesis Development Award supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the TSC research field. The studies supported by this award mechanism are expected to generate preliminary data for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on a strong scientific rationale and study design. Applications should demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis.
Applications must address at least one of the FY2024 focus areas listed in this document.
- The Idea Development Award promotes ideas that have the potential to yield high-impact findings and new avenues of investigation. This award mechanism supports conceptually innovative research that could ultimately lead to critical discoveries in TSC research and/or improvements in patient care. Research projects should include a well-formulated, testable hypothesis based on strong preliminary data and scientific rationale.
Applications must address at least one of the FY2024 focus areas listed in this document.
Funding:
- Clinical Translational Research Award: $ 1M – 1,15M
- Exploration - Hypothesis Development Award: $150,000
- Idea Development Award: $500,000
Duration:
- Clinical Translational Research Award: 3 years
- Exploration - Hypothesis Development Award: 2 years
- Idea Development Award: 3 years
Eligibility:
Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Independent investigators at all career levels are eligible.
How to Apply:
Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline:
- 12 June 2024, 5:00 p.m. Eastern time
Full Application Deadline:
- 01 August 2024, 11:59 p.m Eastern Time
Further information:
- To find the full program announcements and to start your pre-application see here
- A useful summary of each call can be found here
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
- Grants.gov Funding Opportunity Numbers:
- Clinical Translational Research Award: HT942524TSCRPCTRA
- Exploration - Hypothesis Development Award: HT942524TSCRPEHDA
- Idea Development Award: HT942524TSCRPIDA
Practical information
- General public
- Free